- Argentina
- Finland
- Japan
- Senegal
- France
- Korea
- Slovakia
- Australia
- Germany
- Malaysia/Singapore
- South Africa
- Austria
- Greece
- Mexico
- Spain
- Belgium
- Hong Kong
- Netherlands
- Sweden
- Brazil
- Hungary
- New Zealand
- Switzerland
- Canada
- India
- Norway
- Taiwan
- China
- Indonesia
- Pakistan
- Thailand
- Colombia
- Ireland
- Philippines
- Turkey
- Czech Republic
- Israel
- Poland
- United Kingdom
- Denmark
- Italy
- Portugal
- Venezuela
Whether you're just beginning to consider an investment in Pfizer or have been a long-time shareholder in our company, we are committed to providing you with useful information and convenient tools you need to make informed decisions about your investment.
Use our Investment Center to learn more about our company and keep track of your Pfizer investments.
Important Information for Investors
Effective October 27, 2011 Pfizer Inc. completed its acquisition of Icagen, Inc. Pursuant to the terms of the merger, former Icagen shareholders will receive $6.00, in cash (without interest and less any applicable withholding and transfer taxes) for each share of Icagen common stock they owned as of the effective time of the merger.
Pfizer has appointed American Stock Transfer & Trust Company, LLC as paying agent for payment of the merger consideration. Additional information will be mailed to Icagen registered shareholders outlining the steps to be taken to obtain the merger consideration. Shareholders do not need to take any action regarding their shares until contacted by the paying agent. For additional information, please contact American Stock & Trust Company at 877-248-6417 or +1 718-921-8317.
Information for Prospective Investors
Become an informed investor. The links below will help you learn more about investing in Pfizer and get started with your investment.
- Pfizer Stock FAQs
Find answers to investors' frequently asked questions. - 2011 Annual Review (Interactive)
Read our latest annual report to review Pfizer's performance in 2011. - SEC Filings by Pfizer
Review our SEC Filings such as Proxy Statements, 10-K reports, 10-Q reports, 8-K reports, and other public filings.
The Pfizer Shareholder Investment Program
This program offers a simple and expense-free way for non-shareholders to purchase their first shares of Pfizer stock.
Pfizer Pipeline Update – Our Medicines in Development
Visit the Pfizer Pipeline to learn more about exciting breakthroughs with our medicines in development.
Stay on top of Pfizer breaking news: Get News Alerts by RSS.
Stock Quote Disclaimer
20 minute delayed data provided by Comstock. Charts are provided by BigCharts and MarketWatch, Inc. Pfizer makes no claims concerning the accuracy of the information provided on these pages, and will not be held liable for any use of this information. Note: Historical and current stock price performance data is not necessarily indicative of future performance.
Stock Symbol: PFE Stock Exchange: NYSE
Stock Quote at: Apr 20 2012 4:00PM
| Last 22.56 | Change 0.23 |
| %Change | 1.03 | Vol. | 37,798,247 |
| Day High | 22.73 | 52 Wk. High | 22.80 |
| Day Low | 22.28 | 52 Wk. Low | 16.63 |
| Open | 22.31 | Mkt. Cap(Bil) | 170.04 |
| Prev. Close | 22.34 |
- Contact Us
- Investors
- Sitemap
- Careers
- Business to Business
- Terms of Use
- Global Network
- Health Care Professionals
- Privacy Policy
Copyright © 2002–2012 Pfizer Inc. All rights reserved. This information is intended only for residents of the United States. The product information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries. Pfizer Inc. is a pharmaceutical company committed to helping people improve their health by discovering and developing medicines.